688566 Stock Overview
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines.
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥21.28|
|52 Week High||CN¥29.50|
|52 Week Low||CN¥19.80|
|1 Month Change||5.40%|
|3 Month Change||-8.98%|
|1 Year Change||-26.95%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-53.44%|
Recent News & Updates
|688566||CN Pharmaceuticals||CN Market|
Return vs Industry: 688566 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: 688566 underperformed the CN Market which returned 7.5% over the past year.
|688566 Average Weekly Movement||3.2%|
|Pharmaceuticals Industry Average Movement||4.8%|
|Market Average Movement||6.1%|
|10% most volatile stocks in CN Market||9.9%|
|10% least volatile stocks in CN Market||3.5%|
Stable Share Price: 688566 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 688566's weekly volatility (3%) has been stable over the past year.
About the Company
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company’s products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach diseases, and other diseases. The company was founded in 2001 and is based in Zhenjiang, China.
JiangsuJibeier Pharmaceutical Fundamentals Summary
|688566 fundamental statistics|
Is 688566 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|688566 income statement (TTM)|
|Cost of Revenue||CN¥61.79m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.68|
|Net Profit Margin||24.00%|
How did 688566 perform over the long term?See historical performance and comparison
2.3%Current Dividend Yield
Is JiangsuJibeier Pharmaceutical undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 688566 (CN¥21.28) is trading above our estimate of fair value (CN¥12.07)
Significantly Below Fair Value: 688566 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 688566 is good value based on its PE Ratio (31.3x) compared to the CN Pharmaceuticals industry average (31.6x).
PE vs Market: 688566 is good value based on its PE Ratio (31.3x) compared to the CN market (36.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 688566's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 688566 is good value based on its PB Ratio (2.6x) compared to the CN Pharmaceuticals industry average (2.7x).
How is JiangsuJibeier Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as JiangsuJibeier Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has JiangsuJibeier Pharmaceutical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 688566 has high quality earnings.
Growing Profit Margin: 688566's current net profit margins (24%) are higher than last year (21.7%).
Past Earnings Growth Analysis
Earnings Trend: 688566's earnings have grown by 12% per year over the past 5 years.
Accelerating Growth: 688566's earnings growth over the past year (8.1%) is below its 5-year average (12% per year).
Earnings vs Industry: 688566 earnings growth over the past year (8.1%) underperformed the Pharmaceuticals industry 14.8%.
Return on Equity
High ROE: 688566's Return on Equity (8.1%) is considered low.
How is JiangsuJibeier Pharmaceutical's financial position?
Financial Position Analysis
Short Term Liabilities: 688566's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥112.3M).
Long Term Liabilities: 688566's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥87.1M).
Debt to Equity History and Analysis
Debt Level: 688566 is debt free.
Reducing Debt: 688566 had no debt 5 years ago.
Debt Coverage: 688566 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688566 has no debt, therefore coverage of interest payments is not a concern.
What is JiangsuJibeier Pharmaceutical current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 688566's dividend (2.26%) is higher than the bottom 25% of dividend payers in the CN market (0.4%).
High Dividend: 688566's dividend (2.26%) is in the top 25% of dividend payers in the CN market (1.81%)
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 688566's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 688566's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (70.7%), 688566's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
JiangsuJibeier Pharmaceutical has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
JiangsuJibeier Pharmaceutical Co., Ltd.'s employee growth, exchange listings and data sources
- Name: JiangsuJibeier Pharmaceutical Co., Ltd.
- Ticker: 688566
- Exchange: SHSE
- Founded: 2001
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥3.978b
- Shares outstanding: 186.94m
- Website: https://www.jibeier.com.cn
Number of Employees
- JiangsuJibeier Pharmaceutical Co., Ltd.
- High-tech Industrial Development Zone
- Jiangsu Province
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/07 16:33|
|End of Day Share Price||2021/12/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.